Breast cancer is one of the most common cancers affecting women, although it can also occur in men. It begins in the breast cells, often in the milk-producing ducts or the milk glands. The cancer can spread to other body parts, including the lymph nodes and distant organs, if not treated in its early stages.

Types of Breast Cancer:

  • Ductal Carcinoma in Situ (DCIS): A non-invasive cancer where abnormal cells are found in the milk ducts but have not spread to surrounding tissue.
  • Invasive Ductal Carcinoma (IDC): The most common type of breast cancer, IDC, starts in the milk ducts and then spreads to the surrounding tissue.
  • Invasive Lobular Carcinoma (ILC): This type begins in the milk-producing lobules and can spread to other parts of the breast or body.
  • Inflammatory Breast Cancer: A rare but aggressive form that causes the breast to become red, swollen, and warm.
  • Triple-negative Breast Cancer: This type tests negative for estrogen receptors, progesterone receptors, and HER2, making it harder to treat.

Risk Factors:

  • Gender: Women are at higher risk, though men can also develop breast cancer.
  • Age: Risk increases with age, especially after 50.
  • Family History: A family history of breast cancer increases the likelihood, mainly if a close relative was diagnosed at a young age.
  • Genetics: Mutations in genes such as BRCA1 and BRCA2 can significantly increase the risk.
  • Hormone Exposure: Early menstruation, late menopause, or hormone replacement therapy (HRT) can contribute to higher risk.
  • Lifestyle Factors: Poor diet, lack of physical activity, excessive alcohol consumption, and being overweight can increase the risk.

Symptoms:

  • A lump in the breast or underarm
  • Changes in the size, shape, or appearance of the breast
  • Unexplained pain in the breast or nipple
  • Nipple discharge (other than breast milk)

Diagnosis:

  • Mammograms: X-ray images of the breast tissue to look for abnormalities.
  • Ultrasound: High-frequency sound waves to examine the breast tissue.
  • Biopsy: Removal of a tissue sample for examination under a microscope to confirm cancer.
  • MRI: Used in some cases to better visualize abnormalities.

Treatment:

  • Surgery: Removal of the tumor or entire breast (mastectomy).
  • Radiation Therapy: Using high-energy rays to target and kill cancer cells.
  • Chemotherapy: Drugs that destroy cancer cells or stop them from growing.
  • Hormone Therapy: Blocking or lowering the hormones that fuel certain types of breast cancer.
  • Targeted Therapy: Drugs that target specific aspects of cancer cells to stop them from growing.
  • Immunotherapy: A treatment that helps the body’s immune system fight cancer.

Prevention and Early Detection:

  • Regular Screening: Mammograms and self-examinations can help detect breast cancer early.
  • Healthy Lifestyle: A balanced diet, regular physical activity, and limiting alcohol intake can reduce the risk.
  • Genetic Testing: For those with a family history of breast cancer, genetic testing may help assess the risk.
  • Abeclib | 150mg | (Abemaciclib) Quick View
    • Abeclib | 150mg | (Abemaciclib) Quick View
    • ,
    • Abeclib | 150mg | (Abemaciclib)

    • Abeclib 150mg is a potent therapeutic solution designed to target specific health conditions with precision. This detailed guide provides essential information about the medication, including its indications, pharmacology, dosage, interactions, side effects, and more. Whether you are a healthcare professional or a patient seeking clarity, this post offers the insights you need.
    • Read more
  • Afanix 40 Mg (Afatinib) | Medication Of Lung Cancer​ Quick View
    • Afanix 40 Mg (Afatinib) | Medication Of Lung Cancer​ Quick View
    • ,
    • Afanix 40 Mg (Afatinib) | Medication Of Lung Cancer​

    • Afanix 40 Mg, containing the active ingredient Afatinib, is a powerful medication used in the treatment of non-small cell lung cancer (NSCLC). It belongs to the group of medications known as tyrosine kinase inhibitors (TKIs) that target and block specific proteins responsible for cancer cell growth. This makes Afanix 40 Mg an essential treatment option for patients with Medication Of…
    • Read more
  • Hernix 40mg (Neratinib) Quick View
    • Hernix 40mg (Neratinib) Quick View
    • Hernix 40mg (Neratinib)

    • Hernix 40 mg, containing the active ingredientNeratinib, is a groundbreaking oral medication specifically designed for patients withearly-stage Targeted therapy for her2-positive breast cancer. It reduces the risk of cancer recurrence after initial treatments such as surgery or chemotherapy. As a tyrosine kinase inhibitor (TKI), Hernix targets and blocks specific proteins involved in cancer cell growth, helping prevent the spread and…
    • Read more
  • Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer Quick View
    • Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer Quick View
    • ,
    • Hertinib-40mg (Neratinib): HER2 Positive Breast Cancer

    • Hertinib-40mg (Neratinib) is an advanced oral medication specifically designed to treat early-stage HER2-positive breast cancer in patients who have completed prior trastuzumab-based therapy. As a targeted therapy, Hertinib-40mg works by inhibiting the HER2 protein, which is responsible for the growth and spread of cancer cells. By blocking this protein, Hertinib-40mg helps prevent cancer from returning, offering patients improved outcomes and…
    • Read more
  • Olanib 50mg & 150mg (Olaparib)Olanib 50mg & 150mg (Olaparib) Quick View
    • Olanib 50mg & 150mg (Olaparib)Olanib 50mg & 150mg (Olaparib) Quick View
    • , ,
    • Olanib 50mg & 150mg (Olaparib)

    • Olanib 50mg & 150mg (Olaparib) is a leading-edge oral medication used to treat various cancers, specifically ovarian, breast, prostate, and pancreatic cancers. This powerful drug belongs to a class of treatments known as PARP Inhibitor For Prostate Cancer (Poly ADP-Ribose Polymerase inhibitors). It is designed to stop cancer cells from repairing themselves, slowing tumour growth and enhancing survival rates.   
    • Read more
  • Palbocent 125 mg (Palbociclib) Quick View
    • Palbocent 125 mg (Palbociclib) Quick View
    • ,
    • Palbocent 125 mg (Palbociclib)

    • Palbocent 125 mg (Palbociclib) is an innovative oral medication used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Palbociclib, the active ingredient in Palbocent, is a selective inhibitor of cyclin-dependent kinases (CDK) 4 and 6, enzymes that play a crucial role in the growth and division of cancer cells. By blocking…
    • Read more
  • Palbonix 125mg & 100mg (Palbociclib): New breast cancer tre​atmentPalbonix 125mg & 100mg (Palbociclib): New breast cancer tre​atment Quick View
    • Palbonix 125mg & 100mg (Palbociclib): New breast cancer tre​atmentPalbonix 125mg & 100mg (Palbociclib): New breast cancer tre​atment Quick View
    • Palbonix 125mg & 100mg (Palbociclib): New breast cancer tre​atment

    • Palbonix (Palbociclib) is a targeted therapy that has revolutionized the treatment of new breast cancer treatment. Available in 125mg and 100mg doses, Palbonix helps manage hormone receptor-positive and HER2-negative metastatic new breast cancer treatment. It works by inhibiting cyclin-dependent kinases 4 and 6 (CDK 4/6), crucial proteins involved in cell division, slowing down the growth of cancer cells.
    • Read more
  • Palboxen 125mg Quick View
    • Palboxen 125mg Quick View
    • ,
    • Palboxen 125mg

    • Palboxen 125mg, containing the active ingredient Palbociclib, is a groundbreaking medication specifically designed for the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. As a cyclin-dependent kinase (CDK) 4/6 inhibitor, Palboxen 125mg is vital in slowing down the growth and spread of cancer cells, offering hope to patients whose cancer has progressed after previous treatments. When used…
    • Read more
  • Tucaxen 150mg (Tucatinib) | Her2 Positive Breast Cancer Treatment Quick View